Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.2.0.727
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Income Statement [Abstract]        
Collaboration revenue $ 113,636   $ 113,636  
Operating expenses:        
Research and development 1,707,256 $ 169,443 2,430,686 $ 231,360
General and administrative 969,076 294,854 1,780,945 338,582
Total operating expenses 2,676,332 464,297 4,211,631 569,942
Operating loss (2,562,696) (464,297) (4,097,995) (569,942)
Other expense:        
Interest expense (393) (11,232) (1,372) (22,395)
Interest income 548 578 1,108 623
Change in fair value of warrant liability   (29,966)   (28,448)
Foreign currency exchange loss   309   (425)
Other income (expense), net 155 (40,311) (264) (50,645)
Net loss $ (2,562,541) $ (504,608) $ (4,098,259) $ (620,587)
Net loss per share, basic and diluted $ (0.10) $ (0.02) $ (0.16) $ (0.04)
Weighted average number of common shares outstanding, basic and diluted 26,901,100 22,071,172 26,434,174 14,532,561